
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 03, 2025, titled "Press Release - Receipt of USFDA approval".
Filed with NSE ·

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 03, 2025, titled "Press Release - Receipt of USFDA approval".
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories